Recently VC-Funded Companies in the Health Industry (2025)

Executive Summary

This report provides a comprehensive overview of recently venture capital (VC) funded companies in the health industry as of early 2025. The health technology sector is experiencing significant growth, driven by advancements in artificial intelligence (AI), biotechnology, and a favorable economic environment. Digital health startups banked $10.1 billion in venture funding in 2024, and 2025 has started on a high note with several notable funding rounds.

The companies highlighted in this report represent diverse segments of the health industry, including AI-assisted clinical decision support, digital pathology, wireless monitoring solutions, AI-powered imaging tools, and brain data collection and analysis. These companies are at the forefront of innovation, leveraging cutting-edge technologies to address critical healthcare challenges.

Industry Trends Shaping Health Investment in 2025

Digital Health Investment Landscape

Digital health venture capital funding cooled off in 2024 following the fever pitch of investment from 2020 to 2022, with startups securing $10.1 billion in 2024, down from $10.8 billion in 2023 but higher than 2019's funding total. However, 2025 has started with renewed optimism and increased investment activity.

Several key trends are shaping digital health investment in 2025:

AI-Driven Innovation: In 2024, global VC funding for AI-related companies surpassed $100 billion, with a substantial portion directed towards healthcare and biotechnology sectors. This trend is continuing in 2025, with AI technologies becoming increasingly integral to health tech solutions.
Proactive Care and Early Detection: Consumers are increasingly taking control of their own health as traditional healthcare systems struggle to keep up with current trends. More than 50% of chronic disease cases are preventable by adopting proactive healthcare habits, and there's a growing demand for direct access to health data and preventive monitoring solutions.
Operational Efficiency: According to a Deloitte survey, more than 70% of healthcare C-suite executives identified operational efficiencies and productivity gains as top priorities for their organizations in 2025. Healthcare systems face budget constraints, staff shortages, clinician burnout, and pressure to integrate new technologies.
Direct-to-Consumer Models: In 2024, direct-to-consumer (DTC) models outperformed other approaches, largely driven by the rising demand for GLP-1 inhibitors, supplements, and longevity products. This reflects a shift from reactive care to a proactive and preventive approach.
IPO Activity: The maturation of companies backed by VC and PE investments is setting the stage for a robust IPO market in 2025. Companies like Hinge Health and Omada Health are preparing for initial public offerings, reflecting renewed investor confidence.

Investment Activity Outlook

Healthcare's share of global VC deal activity is expected to hold steady at 16.5% in 2025, consistent with its 2023 and 2024 levels. In Europe, AI-driven digital health investment is on track to reach levels not seen since the 2021 boom, with European digital health startups deploying AI raising $701 million so far in 2025.

The healthcare sector is expected to witness robust deal activity in 2025, driven by both strategic acquisitions and financial investments. Analysts anticipate a resurgence in M&A activity, with deals potentially surpassing $10 billion. Private equity firms are poised to increase their investments in healthcare services, particularly in physician practice management and specialized outpatient services.

Recently Funded Health Companies

Navina

Funding Amount: $55 million (Series C)
Lead Investor: Growth Equity at Goldman Sachs Alternatives
Other Investors: Vertex Ventures Israel, Grove Ventures, ALIVE
Total Funding to Date: $100 million
Previous Rounds: $22 million Series B (November 2022), $15 million Series A (October 2021)
Company Focus: AI copilot that assists clinicians at the point of care by presenting actionable insights on patient health history
Technology: Aggregates structured and unstructured clinical data to create patient profiles
Key Partnerships: Agilon (2,800 primary care providers), InnovaCare Health, Millennium Physician Group, Privia Health
Recognition: Won the 2025 Best in KLAS award for clinician digital workflow
Current Reach: Supports 3 million patients and 10,000 healthcare professionals across 1,300 clinics
Expansion Plans: Further expansion into the U.S. market and technology enhancement

Proscia

Funding Amount: $50 million
Lead Investor: Insight Partners
Other Investors: AI Capital Partners (Alpha Intelligence Capital's U.S. fund), Triangle Peak Partners, Avenue Venture Opportunities Fund, Emerald Development Managers, GPG Healthcare, Fusion Fund, Interwoven Ventures, Razor's Edge
Total Funding to Date: $130 million
Company Focus: AI-driven digital pathology platform
Technology: Concentriq platform with three solutions:
- Concentriq LS: Central hub for image-based scientific workflows
- Concentriq AP: Enables laboratories to achieve 100% digitization and adopt AI applications
- Concentriq AP-Dx: FDA 510(k) clearance for primary diagnosis
Current Reach: 16 of the top 20 pharmaceutical companies, on track for more than 22,000 patients to be diagnosed daily
Expansion Plans: Grow customer footprint and advance Concentriq platform, focusing on extending core AI capabilities

Sibel Health

Funding Amount: $30 million (Series C)
Lead Investors: Steele Foundation for Hope, Dräger
Previous Rounds: Series B led by Foundation for Hope ($20M), Series A led by Dräger ($10M)
Company Origin: Spinout of Northwestern University
Company Focus: Wireless monitoring solutions
Technology: ANNE One monitoring platform with clinical-grade wearable sensors for all vital signs
Regulatory Status: Received seventh FDA 510(k) clearance enabling alarms and alerts along with a central station
Key Partnerships: Northwestern Medicine acquired ANNE One systems to evaluate improvements to nursing workflow and patient sleep quality
Executive Quote: "Given the very challenging financing environment, we are ecstatic to see our existing investors fund our entire round given their confidence in our product roadmap and growth trajectory," - Steve Xu M.D., co-founder and CEO of Sibel Health

Inspiren

Funding Amount: $35 million
Company Focus: AI-powered senior living technology
Note: Limited detailed information available

Brainomix

Funding Amount: £14 million ($18 million) (Series C)
Lead Investors: Parkwalk Advisors, Boehringer Ingelheim Venture Fund (BIVF), Hostplus via the IP Group Hostplus Innovation Fund
Company Origin: Spinout from the University of Oxford
Company Focus: AI-powered imaging tools for stroke and lung fibrosis
Technology: Brainomix 360 Stroke platform automates validated imaging biomarkers to improve diagnosis and treatment decisions
Current Reach: Deployed to more than 300 hospitals, benefited more than 1.5 million patients
Clinical Impact: Associated with an additional 50% increase in patients receiving mechanical thrombectomy
Regulatory Status: Recently secured 10 FDA clearances
Expansion Plans: Accelerate commercial expansion into the U.S., advance AI-powered technology in new areas, expand Oxford-based operations and global commercial team
Partnerships: Ongoing partnership with Boehringer Ingelheim to evaluate the real-world impact of e-Lung technology

Brain.space

Funding Amount: $11 million (Series A) + $3.5 million non-dilutive grant by Israel Innovation Authority
Lead Investor: Toyota Ventures
Other Investors: Mangrove Capital Partners, The Group Ventures
Company Focus: Noninvasive brain data collection and analysis
Technology: Brain Sensei headset with 115 dry EEG sensors that operate autonomously and integrate with additional physiological sensors
Innovation: Building a brain-data-as-a-service system for generative AI mental modeling
Key Technology: Patented Brain GPS technology that maps signals to key functional areas of the brain
Recognition: Awarded equity-free grant by Google AI Startups Fund (May 2024), completed Google AI Startups Lab program (January 2025)
Industry Applications: Works with partners in consumer, health, defense, and aerospace industries
Executive Quote: "We are building the largest labeled and standardized Brain Database in the world—with great variety and precision—to design exclusive Mental Modeling that gains actionable, data-based insights about humans' behavior and mental states," - Yair Levy, co-founder and CEO of brain.space

Other Notable Health Companies with Recent Funding

Based on additional research, several other health companies have secured significant funding in 2025:

Evergreen Nephrology

Funding Amount: $130 million
Lead Investors: Rubicon Founders, Oak HC/FT, existing investors, and K2 HealthVentures
Company Focus: Value-based kidney care services
Expansion Plans: Expand across new regions and enhance technological capabilities

Qventus

Funding Amount: $105 million (Series D)
Lead Investors: KKR, Bessemer Venture Partners, with participation from health systems such as Northwestern Medicine, HonorHealth, and Allina Health
Company Focus: AI-based care automation software
Expansion Plans: Accelerate deployment across various healthcare settings

Innovaccer

Funding Amount: $275 million (Series F)
Lead Investors: B Capital Group, Banner Health, Danaher Ventures LLC, Generation Investment Management, Kaiser Permanente, and M12
Company Focus: Healthcare Intelligence Cloud
Expansion Plans: Enhance data integration and analytics for healthcare providers

Conclusion

The health technology sector is experiencing significant growth in 2025, with venture capital flowing into companies that are leveraging AI, biotechnology, and other innovative technologies to address critical healthcare challenges. The companies highlighted in this report represent diverse segments of the health industry and are at the forefront of innovation.

Key trends shaping health investment in 2025 include AI-driven innovation, proactive care and early detection, operational efficiency, direct-to-consumer models, and increased IPO activity. Healthcare's share of global VC deal activity is expected to hold steady at 16.5% in 2025, with robust deal activity driven by both strategic acquisitions and financial investments.

As the health industry continues to evolve, these recently funded companies are well-positioned to drive innovation and improve healthcare outcomes.

References

Fierce Healthcare. (2025, March 5). What's next for digital health investing in 2025? https://www.fiercehealthcare.com/finance/whats-next-digital-health-investing-2025
GoHub Ventures. (2025, March 31). Trends Shaping Digital Health Investment in 2025. https://gohub.vc/digital-health-investment-trends-2025/
Garg, R. (2025, February 19). The 2025 Health Tech Investment Surge. LinkedIn. https://www.linkedin.com/pulse/2025-health-tech-investment-surge-rahul-garg-md-mba--gqbgc

Photo by Abbe Sublett on Unsplash